Treatment of Ischemia-Reperfusion Injury after Lung Transplantation with Ulinastatin in a Left Lung Allograft Model of Rat

XUE Liang,TAN Li-jie,XU Zheng-lang,ZHAO De-ping,ZHENG Ru-heng
DOI: https://doi.org/10.3969/j.issn.1672-8467.2006.01.002
2006-01-01
Abstract:Purpose To investigate the beneficial effects of a protease inhibitor,ulinastatin(UTI),on ischemia reperfusion lung injury,by using an orthotopic single left lung allograft animal model in rats. Methods Sixteen rats were randomly allocated into 2 groups.Control group(n=8) received normal NS in vein just before the reperfusion of the graft.UTI group(n=8) received 10 000 U/kg UTI just before the reperfusion.After 2 hours of reperfusion,the recipient′s arterial blood from the donor lung′s pulmonary vein was taken and blood gases were measured.Then the animals were put to death,and a portion of grafts were taken for microscopic study.Other parts of the donor lungs were frozen in liquid nitrogen and assayed for wet/dry weight ratio,the expression of IL-8,myeloperoxidase(MPO) and ICAM-1 mRNA(measured by RT-PCR) in lung tissue. Results In UTI group,PaO_2/FiO_2 in arterial blood was significantly better [(38.62±0.75) kPa vs(31.57±1.85) kPa,P0.05)] and W/D ratio[(4.74±0.28) vs(5.00±0.12),P0.05],ICAM-1 mRNA, MPO[(0.63±0.23) vs(0.84±(0.22)),P0.05] were significantly lower than in control group.Histological appearances showed less lung tissue damage in UTI group.But the concentrations of IL-8[(173.43±27.64) vs(76.22±12.42),P0.001] in the lung tissue of the UTI group were significantly higher than their counterparts. Conclusions This study demonstrated that ulinastatin prevented lung reperfusion injury after lung transplantation in this model.
What problem does this paper attempt to address?